CBDN — Cbd Global Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -8.96 | -8.93 | -5.25 |
Depreciation | |||
Deferred Taxes | |||
Non-Cash Items | 5.67 | 6.77 | 3.14 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 1.16 | 0.658 | 0.909 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Payable / Accrued Expenses | |||
Change in Other Liabilities | |||
Cash from Operating Activities | -1.94 | -1.34 | -1.14 |
Capital Expenditures | -0.21 | — | -0.003 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | — | 0.055 | 0.224 |
Sale of Business | |||
Sale of Fixed Assets | |||
Cash from Investing Activities | -0.21 | 0.055 | 0.221 |
Financing Cash Flow Items | 0.329 | 0.98 | 1.19 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 1.85 | 1.26 | 1.01 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -0.299 | -0.021 | 0.093 |